[HTML][HTML] PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition
Z Gao, J Xu, Y Fan, Y Qi, S Wang, S Zhao… - Journal of Experimental …, 2022 - Springer
Background Resistance to temozolomide (TMZ) is a major obstacle to preventing
glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) …
glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) …
[HTML][HTML] PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition
Z Gao, J Xu, Y Fan, Y Qi, S Wang, S Zhao… - … of Experimental & …, 2022 - ncbi.nlm.nih.gov
Background Resistance to temozolomide (TMZ) is a major obstacle to preventing
glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) …
glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) …
[HTML][HTML] PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition
Z Gao, J Xu, Y Fan, Y Qi, S Wang… - … of Experimental & …, 2022 - jeccr.biomedcentral.com
Resistance to temozolomide (TMZ) is a major obstacle to preventing glioblastoma (GBM)
recurrence after surgery. Although long noncoding RNAs (lncRNAs) play a variety of roles in …
recurrence after surgery. Although long noncoding RNAs (lncRNAs) play a variety of roles in …
PDIA3P1 Promotes Temozolomide Resistance in Glioblastoma by Inhibiting C/EBPβ Degradation to Facilitate Proneural-to-Mesenchymal Transition
Z Gao, J Xu, Y Fan, Y Qi, S Wang, S Zhao, X Guo… - 2022 - researchsquare.com
Background Resistance to temozolomide (TMZ) is a major obstacle to prevention of
recurrence after surgery for glioblastoma (GBM). Although long noncoding RNAs (lncRNAs) …
recurrence after surgery for glioblastoma (GBM). Although long noncoding RNAs (lncRNAs) …
PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition
Z Gao, J Xu, Y Fan, Y Qi, S Wang… - … of experimental & …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Resistance to temozolomide (TMZ) is a major obstacle to preventing
glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) …
glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) …
PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.
Z Gao, J Xu, Y Fan, Y Qi, S Wang… - … of Experimental & …, 2022 - search.ebscohost.com
Background: Resistance to temozolomide (TMZ) is a major obstacle to preventing
glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) …
glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) …
[PDF][PDF] PDIA3P1 Promotes Temozolomide Resistance in Glioblastoma by Inhibiting C/EBPβ Degradation to Facilitate Proneural-to-Mesenchymal Transition
Z Gao, J Xu, Y Fan, Y Qi, S Wang, S Zhao, X Guo… - scholar.archive.org
Background Resistance to temozolomide (TMZ) is a major obstacle to prevention of
recurrence after surgery for glioblastoma (GBM). Although long noncoding RNAs (lncRNAs) …
recurrence after surgery for glioblastoma (GBM). Although long noncoding RNAs (lncRNAs) …
PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition
Z Gao, J Xu, F Yang, Y Qi, S Wang… - … of Experimental and …, 2022 - search.proquest.com
Background Resistance to temozolomide (TMZ) is a major obstacle to preventing
glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) …
glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) …
PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.
Z Gao, J Xu, Y Fan, Y Qi, S Wang, S Zhao… - … of Experimental & …, 2022 - europepmc.org
Background Resistance to temozolomide (TMZ) is a major obstacle to preventing
glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) …
glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) …
[PDF][PDF] PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition
Z Gao, J Xu, Y Fan, Y Qi, S Wang, S Zhao, X Guo… - 2022 - jeccr.biomedcentral.com
Background: Resistance to temozolomide (TMZ) is a major obstacle to preventing
glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) …
glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) …